Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for MedAvail Holdings, Inc. (MDVL : NSDQ)
 
 • Company Description   
MedAvail Holding Inc. is a technology-enabled pharmacy organization. It engages in providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter and home delivery operations, to Medicare clinics. MedAvail Holding Inc., formerly known as MYOS RENS Technology Inc., is based in MISSISSAUGA, Ontario.

Number of Employees: 287

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.63 Daily Weekly Monthly
20 Day Moving Average: 2,657,170 shares
Shares Outstanding: 32.91 (millions)
Market Capitalization: $53.64 (millions)
Beta: 0.33
52 Week High: $14.59
52 Week Low: $0.79
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.54% -20.06%
12 Week 49.54% 63.38%
Year To Date 16.43% 40.79%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
6665 Millcreek Dr. Unit 1
-
Mississauga,A6 L5N 5M4
CAN
ph: 905-812-0023
fax: 973-348-5707
ir@medavail.com http://www.medavail.com
 
 • General Corporate Information   
Officers
Mark Doerr - Chief Executive Officer and President
Rob Faulkner - Chairman
Ramona Seabaugh - Chief Financial Officer
Gerald Gradwell - Director
Paul Johnson - Director

Peer Information
MedAvail Holdings, Inc. (CHCR)
MedAvail Holdings, Inc. (ESRX)
MedAvail Holdings, Inc. (MYDP)
MedAvail Holdings, Inc. (GBCS)
MedAvail Holdings, Inc. (LAXAF)
MedAvail Holdings, Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 58406B103
SIC: 5912
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 32.91
Most Recent Split Date: 11.00 (0.08:1)
Beta: 0.33
Market Capitalization: $53.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.85 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 8.11
Price/Cash Flow: -
Price / Sales: 1.97
EPS Growth
vs. Year Ago Period: -37.93%
vs. Previous Quarter: -5.26%
Sales Growth
vs. Year Ago Period: 126.32%
vs. Previous Quarter: 25.19%
ROE
03/31/22 - -191.45
12/31/21 - -121.31
09/30/21 - -87.61
ROA
03/31/22 - -105.78
12/31/21 - -83.05
09/30/21 - -67.44
Current Ratio
03/31/22 - 1.70
12/31/21 - 3.65
09/30/21 - 4.64
Quick Ratio
03/31/22 - 1.15
12/31/21 - 3.13
09/30/21 - 4.17
Operating Margin
03/31/22 - -174.11
12/31/21 - -198.00
09/30/21 - -227.51
Net Margin
03/31/22 - -174.11
12/31/21 - -198.00
09/30/21 - -241.08
Pre-Tax Margin
03/31/22 - -174.10
12/31/21 - -197.99
09/30/21 - -241.13
Book Value
03/31/22 - 0.20
12/31/21 - 0.58
09/30/21 - 0.95
Inventory Turnover
03/31/22 - 6.51
12/31/21 - 6.03
09/30/21 - 5.24
Debt-to-Equity
03/31/22 - 1.45
12/31/21 - 0.50
09/30/21 - 0.30
Debt-to-Capital
03/31/22 - 59.22
12/31/21 - 33.34
09/30/21 - 23.27
 

Powered by Zacks Investment Research ©